Published in Eur Heart J on January 01, 1998
Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions. Heart (2005) 0.84
Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High Intensity Transient Signals ReoPro (HITS-RP) study. Cardiovasc Ultrasound (2012) 0.81
Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis. Heart (2002) 0.80
Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study. BMC Cardiovasc Disord (2017) 0.75
Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention. Sultan Qaboos Univ Med J (2010) 0.75
Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention. Tex Heart Inst J (2008) 0.75
The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med (1990) 2.85
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg (2006) 2.74
Periprosthetic leak and rupture after endovascular repair of abdominal aortic aneurysm: the significance of device design for long-term results. J Vasc Surg (1999) 2.55
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin) Thromb Haemost (1997) 1.73
Panic disorder in chest pain patients referred for cardiological outpatient investigation. J Intern Med (1999) 1.55
Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease. Int J Clin Pract (2011) 1.54
Degree of coronary artery disease predicted by exercise testing. J Intern Med (1991) 1.42
Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol (1996) 1.40
[Health centers and family physician]. Tidsskr Nor Laegeforen (1998) 1.37
Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis. Eur J Clin Invest (2005) 1.30
Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand (1982) 1.24
Feasibility of simulating physicians' judgments of patient severity. Med Care (1984) 1.16
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol (1996) 1.15
Effect of linseed oil on platelet adhesiveness and bleeding-time in patients with coronary heart-disease. Lancet (1965) 1.15
A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand (1978) 1.14
Smoke-free hospitals. Attitudes of patients, employees, and faculty. Minn Med (1985) 1.08
Long-term prognosis after out-of-hospital cardiac arrest and primary percutaneous coronary intervention. Resuscitation (2004) 1.07
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia (2005) 1.06
Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost (2000) 1.03
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis (1995) 0.99
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study. J Hum Hypertens (2012) 0.97
n-3 polyunsaturated fatty acids and cardiovascular diseases. Lipids (2001) 0.97
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol (2001) 0.96
Combined administration of dextran 70 and dalteparin does not increase perioperative blood loss compared to dextran 70 alone in major orthopedic surgery. Haemostasis (1999) 0.95
One year's experience of medical intensive care units. Acta Med Scand (1970) 0.95
The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (1999) 0.93
Absence of prophylactic effect of linolenic acid in patients with coronary heart-disease. Lancet (1966) 0.92
Cytoplasmic creatine kinase isoenzymes quantitated in tissue specimens obtained at surgery. Clin Chem (1983) 0.92
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis. Acta Med Scand (1978) 0.91
Anxiety mediates the association between anxiety sensitivity and coping-related drinking motives in alcoholism treatment patients. Addict Behav (2001) 0.91
The natural history of intermediate coronary syndrome. Acta Med Scand (1973) 0.91
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris. Scand J Clin Lab Invest (2008) 0.90
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes. Diabetologia (2006) 0.90
Elective placement of covered stents in native coronary arteries. Acta Radiol (2003) 0.89
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin. Thromb Res (2000) 0.89
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia. Clin Biochem (2004) 0.88
The vitamin D status of man at 70 degrees north. Scand J Clin Lab Invest (1980) 0.88
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase. Scand J Clin Lab Invest (1972) 0.87
Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome. Scand J Clin Lab Invest (2005) 0.87
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest (1998) 0.87
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens (1996) 0.87
Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment. Thromb Res (2008) 0.86
Effects of long-term anticoagulant therapy in subgroups after acute myocardial infarction. Arch Intern Med (1992) 0.86
Serum cardio-specific troponin T after open heart surgery in patients with and without perioperative myocardial infarction. Scand J Clin Lab Invest (1994) 0.85
Anatomy, biomechanics, and pathomechanics of lesser digital deformities. Clin Podiatr Med Surg (1996) 0.85
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol (1997) 0.85
Effects of Ca, Mg, and EDTA on creatine kinase activity in cerebrospinal fluid. Clin Chem (1979) 0.84
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis (2001) 0.84
Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1? J Intern Med (2002) 0.84
Effect of diet intervention on long-term mortality in healthy middle-aged men with combined hyperlipidaemia. J Intern Med (2004) 0.84
Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men. Br J Nutr (2007) 0.84
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.84
Long-term effects of n-3 fatty acids on serum lipids and glycaemic control. Scand J Clin Lab Invest (1994) 0.83
Patient reactions to nutrition education for cholesterol reduction. Am J Prev Med (1991) 0.83
Electrocardiogram in patients with healed myocardial infarction disclosed at autopsy. Acta Med Scand (1966) 0.83
Mortality and cardiovascular morbidity among long-term endurance male cross country skiers followed for 28-30 years. Scand J Med Sci Sports (2011) 0.83
Personality profiles in patients referred for chest pain. Investigation with emphasis on panic disorder patients. Psychosomatics (2000) 0.83
Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism (1995) 0.83
International Federation of Clinical Chemistry, (IFCC), Scientific Committee, Analytical Section. IFCC methods for the measurement of catalytic concentration of enzymes. Part 4. IFCC method for gamma-glutamyltransferase [(gamma-glutamyl)-peptide: amino acid gamma-glutamyltransferase, EC 2.3.2.2]. J Clin Chem Clin Biochem (1983) 0.83
Partially hydrogenated soybean oil reduces postprandial t-PA activity compared with palm oil. Atherosclerosis (2001) 0.83
Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. J Intern Med (2001) 0.83
Mortality in non-consenters in a post-myocardial infarction trial. J Intern Med (1990) 0.82
Serum levels of interleukin-10 are inversely related to future events in patients with acute myocardial infarction. J Thromb Haemost (2004) 0.82
Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease. Scand J Clin Lab Invest (2008) 0.82
N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol (1999) 0.82
Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study. Eur J Clin Nutr (2006) 0.82
Elliptic flow in Au+Au collisions at square root(S)NN = 130 GeV. Phys Rev Lett (2001) 0.82